ID: ALA2303862

Max Phase: Preclinical

Molecular Formula: C17H31NO11

Molecular Weight: 425.43

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  COC[C@@H]1O[C@@H](OC)[C@@H](NC(C)=O)[C@@H](O)[C@@H]1O[C@@H]1O[C@@H](CO)[C@H](O)[C@H](O)[C@@H]1OC

Standard InChI:  InChI=1S/C17H31NO11/c1-7(20)18-10-12(22)14(9(6-24-2)28-16(10)26-4)29-17-15(25-3)13(23)11(21)8(5-19)27-17/h8-17,19,21-23H,5-6H2,1-4H3,(H,18,20)/t8-,9-,10-,11-,12+,13-,14+,15-,16+,17-/m0/s1

Standard InChI Key:  HEBCRUJRIAFVIK-VKDBSKBYSA-N

Associated Targets(Human)

Fucosyltransferase 4 41 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,6-sialyltransferase 61 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 425.43Molecular Weight (Monoisotopic): 425.1897AlogP: -3.29#Rotatable Bonds: 8
Polar Surface Area: 165.40Molecular Species: NEUTRALHBA: 11HBD: 5
#RO5 Violations: 1HBA (Lipinski): 12HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: 12.17CX Basic pKa: CX LogP: -3.06CX LogD: -3.06
Aromatic Rings: 0Heavy Atoms: 29QED Weighted: 0.26Np Likeness Score: 1.57

References

1. Galan MC, Dodson CS, Venot AP, Boons GJ..  (2004)  Glycosyltransferase activity can be selectively modulated by chemical modifications of acceptor substrates.,  14  (9): [PMID:15081009] [10.1016/j.bmcl.2004.02.024]

Source